I-Mab Out-Licenses Rights for Diabetes Drug to CSPC for $22 Million

Life Science

Innovent Sees Positive Data from China Phase III Trial of Avastin Biosimilar

Life Science

WuXi Biologics Congratulates Tychan on First-in-Class Monoclonal Antibody for Yellow Fever after Record 7 Months of Development

Life Science

WuXi AppTec Lists H Shares on the Hong Kong Stock Exchange

Life Science

Airbus Opens China Innovation Center

Technology

Tencent Adds Fiat Chrysler to Growing List of IoV Partners

Technology

Shanghai Junshi Bioscience to Raise $414 Million in Hong Kong IPO

Life Science

WuXi AppTec to Expand Facilities and Hire in San Diego

Life Science

WuXi Biologics Wins SCRIP Award for “Best Company in an Emerging Market”

Life Science

MedMen Opens First Store in Arizona

Cannabis, Life Science

WuXi Biologics Commenced Construction of the Largest Biomanufacturing Facility Using Single-Use Bioreactors in Ireland

Life Science

Revance Announces China Market License Agreement with Fosun Pharma for RT002

Life Science

WuXi Biologics and ABL Bio Enter an Exclusive Development and Clinical Manufacturing Partnership for Multiple Bispecific Antibodies

Life Science

Tencent, Line Ally to Offer WeChat Pay in Japan

Technology

Alibaba and Tencent rally on the back of recent M&A says Yokohama Daisan Management

Technology